Evidence map›Paper›PMID 35574240›Full record

ArticleProceedings. IEEE International Conference on Bioinformatics and Biomedicine2019

Modeling disease progression in Multiple Myeloma with Hopfield networks and single-cell RNA-seq.

Sergii Domanskyi, Alex Hakansson, Giovanni Paternostro, Carlo Piermarocchi

Open access · greenAbstract read
In one paragraph

Article in Proceedings. IEEE International Conference on Bioinformatics and Biomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Sergii DomanskyiMichigan State University, East Lansing, MI, USA.
Alex HakanssonSalgomed, Inc., Del Mar, CA, USA.
Giovanni PaternostroSBP Medical Discovery Institute, La Jolla, CA, USA.
Carlo PiermarocchiMichigan State University, East Lansing, MI, USA.
Michigan State University · USDiscovery Institute · USSalgomed (United States) · US

Funding

Data-driven models of hematological cell fate decision and differentiationR01GM122085 · NIGMS · MICHIGAN STATE UNIVERSITY · PI PIERMAROCCHI, CARLO · 2016 to 2020
$1.8M
NIGMS NIH HHS R01 GM122085
6 · The paper itself

Abstract

Associative memories in Hopfield's neural networks are mapped to gene expression pattern to model different paths of disease progression towards Multiple Myeloma (MM). The model is built using single cell RNA-seq data from bone marrow aspirates of MM patients as well as patients diagnosed with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM), two medical conditions that often progress to full MM. Results: We identify different clusters of MGUS, SMM, and MM cells, map them to Hopfield associative memory patterns, and model the dynamics of transition between the different patterns. The model is then used to identify genes that are differentialy expressed across different MM stages and whose simultaneous inhibition is associated to a delayed disease progression.

Indexed as

cancer disease progressionneural networkssingle cell sequencing data

Identifiers

PMID35574240
PMCPMC9097163
OpenAlexW3004464927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.